Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jstjohn
    Member
    • Jun 2010
    • 35

    #1

    Quantitate study of RIN vs degradation rate for poly-A purification libraries?

    Hello,
    I am interested in using RNA-seq data to identify fusion genes. To do this you need a certain number of reads supporting a given fusion, maybe 10 or so. I am trying to figure out in a systematic way what RIN number is a good lower cutoff for notifying my sequencing provider that they should switch to a ribosomal depletion kit over a poly-A pull down kit. I know about the 3' bias that you get with poly-A pull down if you have degraded RNA. Looking at some coverage data, it looks like there could be a general relation between an exponential decay function and the transcript length that is a function of the RIN number. Has anyone tried to quantify something like this? The problem with just jumping ship over to a ribosomal depletion kit is that I have seen fairly low mapping rates to coding genes in those kits, on the order of 10-20% of all reads. The rest of the reads land in introns or other places on the genome. So say you drop coverage from 1000X down to 100X 3' to 5' in an average length transcript. Isn't that better than a kit where you can only hope for 100X (10X lower) across the entire transcript? So that question is what lead me to want to have this quantified somehow as a function of RIN, so I can make a better decision about when to switch between the two preps based on my needs.

    Is anyone aware of such a study?

    Thanks,
    John

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
52 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
46 views
0 reactions
Last Post SEQadmin2  
Working...